Skip to main content
Premium Trial:

Request an Annual Quote

Roche NimbleGen Certifies UK's NewGene to Offer Sequence Capture Services

Premium

By Justin Petrone

Roche this week said that it has certified NewGene to provide sequence capture services on its microarray and sequencing platforms.

As a certified service provider, Newcastle, UK-based NewGene will provide services for NimbleGen sequence capture arrays with next-generation sequencing on the Genome Sequencer FLX System from Roche's 454 Life Sciences business.

NewGene is the first UK-based services provider to join the Roche NimbleGen CSP network. The molecular diagnostics and research services firm is a partnership between the Newcastle Hospitals National Health System Foundation Trust and Newcastle University.

CEO David Huntley said in a statement that the ability to offer sequence capture services will "provide significant scientific, technical, and economic benefits to our UK customers."

In addition to NewGene, Berlin-based Atlas Biolabs and Ebersberg, Germany-based Eurofins MWG Operon are certified to offer NimbleGen sequence capture services in Europe and Aliso Viejo, Calif.-based Ambry Genetics is certified to offer them in North America.

Financial details of the deal with NewGene were not discussed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.